-
Access to HealthcareAccess to HealthcareInfectious DiseasesMalariaMedical InnovationsTropical DiseasesStaying one step ahead of the malaria parasite
Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.
Access to Healthcare -
Access to HealthcareChronic IllnessEnvironmental SustainabilityInfectious DiseasesMalariaNovartis Institutes for BioMedical ResearchTackling the health toll of climate change
Access to Healthcare -
Access to HealthcareAccess to HealthcareCardiovascular DiseaseHeart DiseaseNovartis AccessPrioritizing the needs of patients
Access to Healthcare -
Access to HealthcareAccess to HealthcareDisease AwarenessGenetic DiseaseLiving With DiseasePatient VoicesBreaking down barriers for patients with sickle cell disease
One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.
Access to Healthcare -
Access to HealthcareDrug DevelopmentInnovationWorking at NovartisTo make a difference, start with patients
John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.
Access to Healthcare -
Access to HealthcareCancerDisease AwarenessFuture of HealthcareOncologyPatient EducationDemystifying the science of myelodysplastic syndromes
Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.
Access to Healthcare -
Access to HealthcareDigitalReimagine MedicineCardiovascular DiseaseFuture of HealthcareAccess to HealthcareExpanding a new digital healthcare solution across chronic heart disease management
More than 100,000 patients with heart failure in China are using our new AI-enabled platform, AI Nurse, to manage their condition and aim for better health.
Access to Healthcare -
Access to HealthcareAccess to HealthcareDiseasesEthical BusinessSocial CommitmentDoing the right thing is good business
Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.
Access to Healthcare -
Access to HealthcareAccess to HealthcareEthical BusinessSocial CommitmentIn your neighborhood: a community-based approach to health equity in the US
Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.
Access to Healthcare -
Access to HealthcareAccess to HealthcareDigitalFuture of HealthcareNeuroscienceFighting MS through innovation
Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).
Access to Healthcare -
Access to HealthcareAccess to HealthcareHeart FailureInfectious DiseasesBringing Chagas disease to people’s attention
Explaining Chagas disease through the stories of patients in Bolivia.
Access to Healthcare -
Access to HealthcareAccess to HealthcareCOVID-19Social CommitmentNovartis joins pharma-wide effort to meet global demand for COVID-19 vaccines
A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.
Access to Healthcare
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- › Next page